A series of aluminum complexes supported by o-phenylene-derived amido phosphine ligands, N-(2-diphenylphosphinophenyl)-2,6-dimethylanilide ([Me-NP]-) and N-(2-diphenylphosphinophenyl)-2,6-diisopropylanilide ([iPr-NP]-), have been prepared. The reactions of trialkylaluminum with H[Me-NP] and H[iPr-NP], respectively, in refluxing toluene produced the corresponding dialkyl complexes [Me-NP]AlR(2) and [iPr-NP]AlR(2) (R = Me, Et). Deprotonation of H[Me-NP] with n-BuLi in THF at -35 degrees C followed by addition of AlCl(3) in toluene at -35 degrees C afforded [Me-NP]AlCl(2), which was subsequently reacted with 2 equiv of trimethylsilylmethyllithium in toluene to give [Me-NP]Al(CH(2)SiMe(3))(2). The aluminum complexes were all characterized by (1)H, (13)C, (31)P, and (27)Al NMR spectroscopy. The solid-state structures of monomeric, four-coordinate [Me-NP]AlEt(2) and [iPr-NP]AlMe(2) and five-coordinate [Me-NP]AlCl(2)(THF) were determined by X-ray crystallography. The (1)H NMR studies of [Me-NP]AlEt(2), [Me-NP]Al(CH(2)SiMe(3))(2), and [iPr-NP]AlEt(2) indicate diastereotopic alpha-hydrogen atoms in these molecules. Heteronuclear COSY and NOE experiments suggest that the phosphorus donor in [Me-NP]Al(CH(2)SiMe(3))(2) and [iPr-NP]AlEt(2) is coupled to only one of the diastereotopic alpha-hydrogen atoms that is virtually antiperiplanar with respect to the phosphorus atom.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: